Help save our prevention, testing, treatment and research programs threatened by U.S. government budget cuts

Support for the research and programs at the Hepatitis B Foundation and Blumberg Institute is being threatened by changes within the U.S. government. We need strong action. Every moment we wait puts lives at risk. 

Please donate now and protect the future of hepatitis B research and treatment.

Stay informed and follow us on social media for updates on how to help us #BeBold. 

New B Informed Training Hub course:

Preventing mother-to-child transmission

We're excited to announce a new B Informed Training Hub course: Preventing Mother-to-Child Transmission (PMTCT). This comprehensive course is designed to empower health care providers, advocates and community leaders with the tools and knowledge to prevent the transmission of hepatitis B from mothers to their newborns.

Join the B Informed Training Hub and gain the knowledge needed to help eliminate mother-to-child transmission of hepatitis B. Explore the course and take the first step toward making a difference in your community.

Start your learning journey today by clicking here.

March is National Nutrition Month, a time to prioritize health and well-being through a balanced diet.

For people living with chronic hepatitis B, good nutrition plays a key role in supporting liver health and overall wellness.

Certain foods, such as cruciferous vegetables including cabbage, broccoli and cauliflower, have been shown to help protect the liver from harmful environmental chemicals. Additionally, everything consumed through eating, drinking, or absorbed through the skin is eventually filtered by the liver. Choosing nutrient-rich foods such as fresh fruits, whole grains, fish, lean meats and fresh vegetables can support liver function and overall health.

Explore our full list of liver-friendly tips to learn how to better care for your liver and overall well-being. Learn more about healthy diets for hepatitis B and liver care here.

Let's make this National Nutrition Month a time to prioritize health and support liver wellness.

Create the Connection: Making the Link between Hep B and Liver Cancer

Are you an artist? Submit an entry to the Hepatitis B Foundation’s Learn the Link contest! Create any type of original multimedia artwork using the tagline “Learn the Link,” and highlighting the connection between hepatitis B and liver cancer.

The winning entries will be shared broadly and featured on different materials that have global reach, especially for Hepatitis Awareness Month in May, World Hepatitis Day in July, and Liver Cancer Awareness Month in October!

Featured #BtheVoice storytellers from Africa

Voices of Resilience: Stories of Hope and Advocacy

Ibrahim, Nigeria

Across Africa, people living with hepatitis B are turning their experiences into powerful advocacy. Jane, diagnosed at 20 in Nigeria, faced isolation after contracting the virus from her mother, who later passed away. Now, she encourages others to get tested and challenge stigma. Ibrahim discovered his diagnosis while seeking help for his mother, balancing financial struggles with his health, and urging others to follow medical advice. Irinam, a life scientist counseling others on viral hepatitis, found himself on the other side of the diagnosis. His journey highlights that hepatitis B is treatable and the value of lived experiences in advocacy.

Prince, Nigeria

Prince learned of his diagnosis during a community blood drive, inspiring him to create an organization raising awareness and partnering with the government. Teresa, diagnosed during mass testing after fleeing the South Sudan war, advocates for screening pregnant women to protect newborns and combat stigma.

Visit our storytelling website for more stories from real people living with hepatitis B and liver cancer worldwide.

B Heppy Podcast:

Why the hepatitis B vaccine needs to be prioritized! 

Michaela Jackson, MPH, MS

Program Director of

Prevention and Policy

In the latest episode the B Heppy podcast, Bright and Anousha sit down with Michaela Jackson, Program Director of Prevention and Policy at the Hepatitis B Foundation, to discuss the importance of the hepatitis B vaccine and why it must be prioritized in global health efforts.

Michaela shares key insights on how the hepatitis B birth dose vaccine plays a critical role in preventing mother-to-child transmission and protecting future generations.

Learn more about the hepatitis B birth dose and vaccination by visiting our Hepatitis B Birth Dose Media Toolkit here.

Latest Blog: AGA publishes new guidelines

on hepatitis B reactivation

The American Gastroenterological Association (AGA) has released updated guidelines to prevent and manage hepatitis B reactivation (HBVr) in at-risk individuals. HBVr is a significant health concern, particularly for those undergoing cancer treatment or taking immunosuppressive medications.

Read the full blog to learn more about the new guidelines

and how they can help protect those at risk here.

We are proud to share that Michelle Liu, MPH, Advocacy and Engagement Program Manager, attended the HCC-LIVE Conference 2025 Feb. 20-22 in Austin, Texas. Organized by Focus Medical Communications, LLC, HCC-LIVE is said to become the premier North American liver cancer meeting.

Michelle participated in sessions highlighting the latest advancements in liver cancer, including debates, tumor boards and discussions on innovative technologies. Our abstract on storytelling's impact on addressing hepatitis B and liver cancer disparities was showcased in the exhibit hall, bringing attention to the power of lived experiences in raising awareness and driving change.

We were also honored to have Alan, one of our #justB storytellers, share his journey with hepatitis B on the patient panel. His story highlighted the importance of patient advocacy and the need for equitable access to care.

We're grateful for the opportunity to represent the hepatitis B community and continue advocating for improved liver cancer prevention and treatment.

Learn more about our storytelling program here.

The Hepatitis B Foundation has launched a hepatitis delta survey, in order to better understand the experiences of people who living with hepatitis delta, from testing to diagnosis to management. We hope this will lead to a better understanding of the virus and help us advocate for better testing and treatment.

The survey should take less than 10 minutes to complete. There's an option to participate in a short interview to further discuss your experiences. The survey, which has been translated into 14 languages, can be found here.

New clinical trial opportunity available for people

living with chronic hepatitis B virus infection 

Check out this new clinical trial opportunity! GSK is launching a phase 2b study called B-United, which will test a study drug called daplusiran/tomligisiran (DAP/TOM) followed by another study drug called bepirovirsen as a potential new treatment for chronic hepatitis B virus infection.

You may be eligible to participate in the B-United study if you: 

• Are at least 18 years old (the minimum age may be higher in some countries);  
• Have had diagnosed chronic hepatitis B infection documented for at least six months;  
• Have been on stable nucleoside/nucleotide analogue (NA) treatment (sometimes referred to as antivirals, such as tenofovir or entecavir) for the past 6 months, without any changes for the past 3 months.

If eligible, you will continue NA treatment and receive an investigational therapy that consists of: 

1. daplusiran/tomligisiran OR placebo for 24 weeks followed by 
2. bepirovirsen for 24 weeks 



Following study treatment with daplusiran/tomligisiran (or placebo) and bepirovirsen, you will continue your NA treatment for 24 more weeks. The study doctor will then determine if you can stop your NA treatment and, if so, you will be off-NA treatment for up to 28 weeks while closely monitored by the study doctor. 

The study is being run in many countries around the world.

To find out more information and see if you might be eligible,

please visit www.BUnitedStudy.com. 

 Seeking youth & adolescent perspectives on hepatitis B

The Hepatitis B Foundation wants to learn about the experiences of young people living with hepatitis B to improve care and support. We are asking all

youth living with hep B to participate in a brief survey. Their insights will help inform clinicians and health care professionals about the unique needs of youth and adolescents. Sign up here.

Questions? Reach out to Catherine.Freeland@hepb.org

Summary: The abrupt dismantling of global health infrastructure by the new U.S. administration poses a critical threat to public health worldwide. Recent policy changes—including the U.S. withdrawal from the World Health Organization, suspension of critical public health reports and end to key partnerships—jeopardize decades of progress in disease prevention and health equity.